These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36165153)

  • 1. Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever.
    Yildirim T; Yilmaz R; Saglam A; Uzerk-Kibar M; Jabrayilov J; Erdem Y
    Nefrologia (Engl Ed); 2021; 41(6):632-639. PubMed ID: 36165153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever.
    Yildirim T; Yilmaz R; Saglam A; Uzerk-Kibar M; Jabrayilov J; Erdem Y
    Nefrologia (Engl Ed); 2021 Mar; ():. PubMed ID: 33741173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
    Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.
    Sendogan DO; Saritas H; Kumru G; Eyupoglu S; Sadioglu RE; Tuzuner A; Sengul S; Keven K
    Transplant Proc; 2019 Sep; 51(7):2292-2294. PubMed ID: 31400972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H; Varan O; Kucuk H; Atas N; Satis H; Salman R; Ozturk MA; Goker B; Tufan A; Haznedaroglu S
    J Clin Rheumatol; 2020 Jan; 26(1):7-13. PubMed ID: 30048391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever.
    Sozeri B; Gulez N; Ergin M; Serdaroglu E
    Mol Cell Pediatr; 2016 Dec; 3(1):33. PubMed ID: 27590627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.
    Yildirim T; Yilmaz R; Uzerk Kibar M; Erdem Y
    J Nephrol; 2018 Jun; 31(3):453-455. PubMed ID: 29446001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y; Gezer HH; Duruöz MT
    Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with familial Mediterranean fever: a propensity score-matched cohort study.
    Mirioglu S; Dirim AB; Bektas M; Demir E; Tor YB; Ozluk Y; Kilicaslan I; Oto OA; Yalcinkaya Y; Caliskan Y; Artim-Esen B; Yazici H; Inanc M; Turkmen A; Gul A; Sever MS
    Nephrol Dial Transplant; 2023 May; 38(5):1327-1336. PubMed ID: 36542475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB; Özdel S; Yılmaz S; Kurt-Şükür ED; Ekim M; Yalçınkaya F
    Clin Rheumatol; 2016 Feb; 35(2):441-6. PubMed ID: 25213327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
    Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Hip Joint Replacement in a Patient with Colchicine-Resistant Familial Mediterranean Fever under Canakinumab Treatment.
    Matsumoto H; Ohashi H; Fujita Y; Yoshida S; Yokose K; Temmoku J; Matsuoka N; Shinden Y; Kusano K; Sonobe T; Nakamoto Y; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Watanabe H; Migita K
    Tohoku J Exp Med; 2022 Feb; 256(2):169-174. PubMed ID: 35236806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study.
    Tomokawa T; Koga T; Endo Y; Michitsuji T; Kawakami A
    Mod Rheumatol; 2022 Jul; 32(4):797-802. PubMed ID: 34897516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between basal proteinuria levels and pregnancy outcomes in familial Mediterranean fever.
    Iskender D; Kara O; Ozturk Kaymak A; Daglar HK; Kirbas A; Iskender CT; Kaymak O; Celen S
    J Obstet Gynaecol; 2020 Nov; 40(8):1102-1105. PubMed ID: 32270724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canakinumab treatment in children with familial Mediterranean fever: report from a single center.
    Yazılıtaş F; Aydoğ Ö; Özlü SG; Çakıcı EK; Güngör T; Eroğlu FK; Gür G; Bülbül M
    Rheumatol Int; 2018 May; 38(5):879-885. PubMed ID: 29450637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis.
    Kisla Ekinci RM; Balci S; Dogruel D; Altintas DU; Yilmaz M
    Paediatr Drugs; 2019 Oct; 21(5):389-395. PubMed ID: 31463794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists.
    Suticen E; Atas N; Guler AA; Akdogan O; Babaoğlu H; Satis H; Karadeniz H; Haznedaroglu S; Ozturk MA; Tufan A
    Clin Rheumatol; 2021 Jul; 40(7):2865-2871. PubMed ID: 33527168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.